Pantoprazole and Docetaxel for Men With Metastatic Castration-Resistant Prostate Cancer - a Single Arm Phase II Clinical Trial With a Predefined Reference Group (PANDORA)
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Pantoprazole (Primary) ; Docetaxel
- Indications Prostate cancer
- Focus Therapeutic Use
- Acronyms PANDORA
- 23 Mar 2021 Biomarkers information updated
- 23 Jan 2013 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 14 Jan 2013 New trial record